Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan

The present investigation was focused to formulate semi-solid capsules (SSCs) of hydrophobic drug telmisartan (TLMS) by encapsulating semi-solid matrix of its solid dispersion (SD) in HPMC capsules. The combinational approach was used to reduce the lag time in drug release and improvise its dissolut...

Full description

Bibliographic Details
Main Authors: Syed Faisal Ali, Monika Joshi, Nida Akhtar, Vijay Sharma, Kamla Pathak
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2016-02-01
Series:Pharmaceutical and Biomedical Research
Subjects:
Online Access:http://pbr.mazums.ac.ir/browse.php?a_code=A-10-53-2&slc_lang=en&sid=1
_version_ 1818852243293601792
author Syed Faisal Ali
Monika Joshi
Nida Akhtar
Vijay Sharma
Kamla Pathak
author_facet Syed Faisal Ali
Monika Joshi
Nida Akhtar
Vijay Sharma
Kamla Pathak
author_sort Syed Faisal Ali
collection DOAJ
description The present investigation was focused to formulate semi-solid capsules (SSCs) of hydrophobic drug telmisartan (TLMS) by encapsulating semi-solid matrix of its solid dispersion (SD) in HPMC capsules. The combinational approach was used to reduce the lag time in drug release and improvise its dissolution. SDs of TLMS was prepared using hot fusion method by varying the combinations of Pluronic-F68, Gelucire 50/13 and Plasdone S630. A total of nine batches (SD1-SD9) were characterized for micromeritic properties, in vitro dissolution behavior and surface characterization. SD4 with 52.43% cumulative drug release (CDR) in phosphate buffer, pH 7.4, in 120 min, t50% 44.2 min and DE30min 96.76% was selected for the development of semi-solid capsules. Differential scanning calorimetry of SD4 revealed molecular dispersion of TLMS in Pluronic-F68. SD4 was formulated into SSCs using Gelucire 44/14 and PEG 400 as semi-solid components and PEG 6000 as a suspending agent to achieve reduction in lag time for effective drug dissolution. SSC6 showed maximum in vitro drug dissolution 97.49 % in phosphate buffer, pH 7.4 with in 20 min that was almost a three folds reduction in the time required to achieve similar dissolution by SD. Thus, SSCs present an excellent approach to enhance in vitro dissolution as well as to reduce the lag time of dissolution for poorly water soluble drugs especially to those therapeutic classes that are intended for faster onset of action. Developed approach based on HPMC capsules provided a better alternative to target delivery of telmisartan to the vegetarian population.
first_indexed 2024-12-19T07:17:49Z
format Article
id doaj.art-124a7e3ceb254bfdb94eb9a8bf09e05a
institution Directory Open Access Journal
issn 2423-4486
2423-4494
language English
last_indexed 2024-12-19T07:17:49Z
publishDate 2016-02-01
publisher Mazandaran University of Medical Sciences
record_format Article
series Pharmaceutical and Biomedical Research
spelling doaj.art-124a7e3ceb254bfdb94eb9a8bf09e05a2022-12-21T20:31:01ZengMazandaran University of Medical SciencesPharmaceutical and Biomedical Research2423-44862423-44942016-02-01212335Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartanSyed Faisal Ali0Monika Joshi1Nida Akhtar2Vijay Sharma3Kamla Pathak4 Department of Pharmaceutics, Pharmacy College Saifai, Saifai, Etawah, Uttar Pradesh, India Department of Pharmaceutics, Pharmacy College Saifai, Saifai, Etawah, Uttar Pradesh, India Department of Pharmaceutics, Pharmacy College Saifai, Saifai, Etawah, Uttar Pradesh, India Department of Pharmaceutics, Pharmacy College Saifai, Saifai, Etawah, Uttar Pradesh, India Department of Pharmaceutics, Pharmacy College Saifai, Saifai, Etawah, Uttar Pradesh, India The present investigation was focused to formulate semi-solid capsules (SSCs) of hydrophobic drug telmisartan (TLMS) by encapsulating semi-solid matrix of its solid dispersion (SD) in HPMC capsules. The combinational approach was used to reduce the lag time in drug release and improvise its dissolution. SDs of TLMS was prepared using hot fusion method by varying the combinations of Pluronic-F68, Gelucire 50/13 and Plasdone S630. A total of nine batches (SD1-SD9) were characterized for micromeritic properties, in vitro dissolution behavior and surface characterization. SD4 with 52.43% cumulative drug release (CDR) in phosphate buffer, pH 7.4, in 120 min, t50% 44.2 min and DE30min 96.76% was selected for the development of semi-solid capsules. Differential scanning calorimetry of SD4 revealed molecular dispersion of TLMS in Pluronic-F68. SD4 was formulated into SSCs using Gelucire 44/14 and PEG 400 as semi-solid components and PEG 6000 as a suspending agent to achieve reduction in lag time for effective drug dissolution. SSC6 showed maximum in vitro drug dissolution 97.49 % in phosphate buffer, pH 7.4 with in 20 min that was almost a three folds reduction in the time required to achieve similar dissolution by SD. Thus, SSCs present an excellent approach to enhance in vitro dissolution as well as to reduce the lag time of dissolution for poorly water soluble drugs especially to those therapeutic classes that are intended for faster onset of action. Developed approach based on HPMC capsules provided a better alternative to target delivery of telmisartan to the vegetarian population.http://pbr.mazums.ac.ir/browse.php?a_code=A-10-53-2&slc_lang=en&sid=1in vitro dissolution lag time HPMC capsules solid dispersion solubility
spellingShingle Syed Faisal Ali
Monika Joshi
Nida Akhtar
Vijay Sharma
Kamla Pathak
Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan
Pharmaceutical and Biomedical Research
in vitro dissolution
lag time
HPMC capsules
solid dispersion
solubility
title Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan
title_full Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan
title_fullStr Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan
title_full_unstemmed Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan
title_short Combinational approach using solid dispersion and semi-solid matrix technology to enhance in vitro dissolution of telmisartan
title_sort combinational approach using solid dispersion and semi solid matrix technology to enhance in vitro dissolution of telmisartan
topic in vitro dissolution
lag time
HPMC capsules
solid dispersion
solubility
url http://pbr.mazums.ac.ir/browse.php?a_code=A-10-53-2&slc_lang=en&sid=1
work_keys_str_mv AT syedfaisalali combinationalapproachusingsoliddispersionandsemisolidmatrixtechnologytoenhanceinvitrodissolutionoftelmisartan
AT monikajoshi combinationalapproachusingsoliddispersionandsemisolidmatrixtechnologytoenhanceinvitrodissolutionoftelmisartan
AT nidaakhtar combinationalapproachusingsoliddispersionandsemisolidmatrixtechnologytoenhanceinvitrodissolutionoftelmisartan
AT vijaysharma combinationalapproachusingsoliddispersionandsemisolidmatrixtechnologytoenhanceinvitrodissolutionoftelmisartan
AT kamlapathak combinationalapproachusingsoliddispersionandsemisolidmatrixtechnologytoenhanceinvitrodissolutionoftelmisartan